Spotlight on Augmentiqs: Redefining Digital Pathology

Spotlight on Augmentiqs podcast
Forward Faster
Forward Faster
Spotlight on Augmentiqs: Redefining Digital Pathology
/

When a patient is diagnosed with cancer today, a pathologist will look at a tumor sample and attempt to suggest the best treatment based on what they see in the microscope, which remains principally an analog technology. Augmentiqs is helping pathologists make more accurate interpretations and informed decisions for better patient outcomes by digitizing the microscope. Luminate Managing Director, Dr. Sujatha Ramanujan, sat down with clinical specialists at Augmentiqs, Marcus D’Aguiar and Brandon Buscaglia, to discuss how this startup is transforming the future of pathology. Hear how Augmentiqs is turning the microscope into a connected device, their thoughts on the exciting future of telepathology and 3D tumor modeling, and what it was like to participate in the second cohort of the Luminate accelerator.

Learn more about Augmentiqs at www.augmentiqs.com.

Stay in the Loop!

Subscribe to NextCorps communications to stay up-to-date on what’s happening in the region’s startup community, including info on upcoming events and opportunities that can help forward your business. No spam. No ads. Unsubscribe at any time.

This field is for validation purposes and should be left unchanged.